Attachment 1 Avient Announces Quarterly Dividend... Avient Board of Directors Appoints Ashish K.

Pro Forma Financial Information The Company acquired Avient Protective Materials (“Dyneema”) on September 1, 2022 (the “Acquisition Date”) and sold the Distribution segment on November 1, 2022. To provide comparable results, the company references “pro forma” financial metrics, which include the business results of Avient Protective Materials for periods prior to the Acquisition Date, as if the transaction occurred on January 1, 2021 and reflect Distribution as a discontinued operation. Continue fostering our Great Place to Work® culture Strategic Objectives Long Term Growth Rates Growth Drivers $340 $455 $790 $1,135 $51 $84 $212 $645 $108 $113 $231 $230 $265 $358 $726 $725 8-12% 8-10% 8-10% 5% Sustainable Solutions Composites Healthcare Asia/Emerging Regions Profitable Growth Great Place to Work 5.4% 10.9% 16.0% 2006 2014 2023 EBITDA Margins $0.14 $1.93 $2.36 2006 2014 2023 TOP-TIER SUSTAINABILITY PERFORMANCE AND RECOGNITION Industry Sustainability Standards ESG Ratings Performance 1 4 87th 94th percentile 5 Avient CDP Score: A- FE BRUARY 14 , 2024 W E BCAS T P RE S E N TAT I O N DR.

Office Supplies Pet Care & Supplies Auto-injectors and Drug Delivery Pens

per share (see Attachment 1).  Attachment 1 Special items (1)

Attachment 1 Special items (1) 1)

Office Supplies Pet Care & Supplies Auto-injectors and Drug Delivery Pens

The market requirements for colored, high-performance polymers are clear: you have to react quickly and also be able to supply various volumes of colored material,” says Anne Hippert, general manager, Colorant Chromatics at Avient. About Avient Avient Announces Quarterly Dividend...

Avient’s chief operating decision maker uses these financial measures to monitor and evaluate the ongoing performance of Avient and each business segment and to allocate resources. Pro Forma Financial Information The Company acquired Avient Protective Materials (“Dyneema”) on September 1, 2022 (the “Acquisition Date”) and sold the Distribution segment on November 1, 2022. Avient Specialty Other Specialty / 2023E(%) 31 79 87 81 79 76 73 90 77 76 75 73 64 59 33 MULTIPLE EXPANSION Avient Specialty Other Specialty / Note: Avient reflects 2023 adjusted EBITDA guidance of $530M and closing share price of $38.89.

Office Supplies Pet Care & Supplies Auto-injectors and Drug Delivery Pens

Attachment 1 Special items (1) 1)